Growth Metrics

Protalix BioTherapeutics (PLX) EBT Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 441.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,297.00
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 9,326.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,326.00
Dec 31, 2025 -382.00
Sep 30, 2025 3,769.00
Jun 30, 2025 6,516.00
Mar 31, 2025 -2,269.00
Dec 31, 2024 14,249.00
Sep 30, 2024 5,703.00
Jun 30, 2024 16,003.00
Mar 31, 2024 -7,451.00
Dec 31, 2023 -21,194.00
Sep 30, 2023 2,560.00
Jun 30, 2023 9,420.00
Mar 31, 2023 -3,738.00
Dec 31, 2022 -3,805.00
Sep 30, 2022 7.00
Jun 30, 2022 231.00
Mar 31, 2022 5,719.00
Dec 31, 2021 23,773.00
Sep 30, 2021 80,177.00
Jun 30, 2021 24,868.00
Mar 31, 2021 11,012.00
Dec 31, 2020 58,485.00
Sep 30, 2020 10,986.00
Jun 30, 2020 17,965.00
Mar 31, 2020 52,025.00
Dec 31, 2019 49,080.00
Sep 30, 2019 13,662.00
Jun 30, 2019 54,908.00
Mar 31, 2019 121,991.00
Sep 30, 2018 -38,591.00
Jun 30, 2018 4,044.00
Mar 31, 2018 22,469.00
Mar 31, 2017 -40,323.00
Dec 31, 2016 -70,064.00
Sep 30, 2016 8,531.00
Jun 30, 2016 -30,782.00
Mar 31, 2016 -116,679.00
Sep 30, 2015 -30,220.00
Jun 30, 2015 -50,286.00
Mar 31, 2015 -22,950.00
Mar 31, 2014 1,178.00
Dec 31, 2013 96,301.00
Sep 30, 2013 -15,771.00
Jun 30, 2013 58,507.00